As per the RHP, the company's financial data is based on Restated Consolidated Financial Information prepared under Indian ...

Canadian generic drug manufacturer Apotex Inc. is planning an initial public offering in Toronto during the first half of the year that could raise as much as C$1 ...

Generate Biomedicines has filed for an initial public offering on Monday, aiming to raise as much as $425 million in the United States. The biotechnology company ...

As of now, Kalshi remains a privately held company that has not publicly announced plans to launch an IPO in 2026 or any other time. In a sense, this should not surprise anyone, as companies tend to ...

The Global Real Assets Fund A Shares (without sales charge*) posted a return of 2.75% in fourth quarter 2025. Read more here.

Investing.com - Generate Biomedicines, Inc. filed to raise up to $425 million in an initial public offering on The Nasdaq Stock Market under the symbol "GENB." The clinical-stage generative biology ...

A SpaceX IPO Is Coming, but You Don't Have to Wait. Here's How Retail Investors Can Buy SpaceX Shares Right Now. The space ...

Bangladesh share market trends in 2026, DSE index performance, IPO growth, risks, and smart investment outlook for long-term ...

OpenAI plans to spend about $600 billion on computing infrastructure by 2030 as it eyes an IPO and rapid AI growth.

The Wealth Company Asset Management, India's newest fund house, is making waves. CEO Madhu Lunawat is prioritizing ...

Moneycontrol spoke to John Kallelil, Founder & Managing Director, and Piyush Agrawal, Chief Financial Officer, about the ...